Induction Toripalimab and Chemotherapy in Locally Advanced Cervical Cancer
Status:
Recruiting
Trial end date:
2026-07-01
Target enrollment:
Participant gender:
Summary
To explore the efficacy of incorporating neoadjuvant immunotherapy into neoadjuvant
chemotherapy in locally advanced cervical cancer patients with high risk of recurrence.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Tianjin Medical University Cancer Institute and Hospital